Literature DB >> 29469775

Coexistence of keloids and pilomatricoma in a patient with Rubinstein-Taybi syndrome.

Yosuke Yagi1, Yutaka Kuwatsuka, Misachi Asai, Mai Honda, Atsushi Utani.   

Abstract

Rubinstein-Taybi syndrome (RTS) is an autosomaldominant hereditary disease, which contains many skeletal and organ anomalies as well as mental retardation. Although high incidence of keloids in RTS is known, it is difficult to find a detailed report on the clinical features of keloids. In the following letter, we report an RTS patient fulfilling diagnostic criteria whosuffered from both keloids and pilomatricoma. We also performed a literature search, which identified the possible involvement of the Wnt/β-catenin signaling pathway in the pathogenesis of these two skin lesions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29469775

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  4 in total

Review 1.  The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago.

Authors:  Rei Ogawa
Journal:  Plast Reconstr Surg       Date:  2022-01-01       Impact factor: 4.730

2.  A novel CREBBP mutation and its phenotype in a case of Rubinstein-Taybi syndrome.

Authors:  Qian Wang; Cong Wang; Wen Bin Wei; Wei Ning Rong; Xiang Yu Shi
Journal:  BMC Med Genomics       Date:  2022-08-19       Impact factor: 3.622

3.  Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome.

Authors:  Ana Laura Andrade Bueno; Maria Emilia Vieira de Souza; Carla Graziadio; Ana Elisa Kiszewski
Journal:  An Bras Dermatol       Date:  2020-07-15       Impact factor: 1.896

4.  No Evidence of Abnormal Expression of Beta-Catenin and Bcl-2 Proteins in Pilomatricoma as One Clinical Feature of Tetrasomy 9p Syndrome.

Authors:  Chariyawan Charalsawadi; Sasipong Trongnit; Kanoot Jaruthamsophon; Juthamas Wirojanan; Somchit Jaruratanasirikul; Anupong Nitiruangjaras; Pornprot Limprasert
Journal:  Int J Pediatr       Date:  2021-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.